What are the recommended preparation, dosing, syringe‑pump settings, and monitoring for a norepinephrine (noradrenaline) infusion in adults and children?

Noradrenaline Infusion in Syringe Pump

For adults, prepare norepinephrine by diluting 4 mg (4 mL) in 1000 mL of 5% dextrose to yield 4 mcg/mL, start at 2-4 mcg/min (0.5-1 mL/min) via syringe pump, and titrate to maintain systolic blood pressure 80-100 mmHg with continuous hemodynamic monitoring. 1

Preparation and Dilution

Standard Adult Concentration

• Dilute 4 mg (4 mL) of norepinephrine in 1000 mL of 5% dextrose to achieve 4 mcg/mL concentration 1
• Use 5% dextrose injection or 5% dextrose with sodium chloride - these dextrose-containing fluids protect against oxidation 1
• Avoid saline-only solutions as they do not provide adequate protection against drug degradation 1

Critical Mixing Technique

Mix the syringe contents by turning it top-to-bottom in a 180° shaking movement 5 consecutive times with an air bubble present - this ensures homogeneous drug concentration throughout administration 2. Without proper mixing, drug concentrations can vary widely during infusion, potentially delivering unpredictable doses 2. This mixing step should be mandatory before any syringe pump administration.

Pediatric Concentrations

For children requiring norepinephrine infusion, the preparation differs:

• Use the "rule of 6": 0.6 × body weight (kg) = number of mg diluted to 100 mL saline
• Then 1 mL/h delivers 0.1 mcg/kg/min 3

Dosing

Adults

• Initial dose: 2-3 mL/min (8-12 mcg/min) of the 4 mcg/mL solution 1
• Maintenance dose: 0.5-1 mL/min (2-4 mcg/min) - this is the average range 1
• Weight-based equivalent: 0.05-0.3 mcg/kg/min for most patients 4
• Maximum doses may reach 68 mg/day (17 vials) in refractory shock, though occult volume depletion should always be suspected at high doses 1

Pediatric Dosing

• Start at 0.05 mcg/kg/min and titrate up to 0.3 mcg/kg/min 4
• Mean doses in clinical practice: starting 0.5 ± 0.4 mcg/kg/min, maximum 2.5 ± 2.2 mcg/kg/min 5
• Higher doses than traditionally recommended may be necessary to reverse hypotension 5

Dose Titration Strategy

• Titrate to maintain systolic BP 80-100 mmHg in previously normotensive patients 1
• In previously hypertensive patients, raise BP no higher than 40 mmHg below pre-existing systolic pressure 1
• Adjust rate based on continuous blood pressure response 1

Syringe Pump Settings and Administration

Infusion System Considerations

Use a double-syringe pump system with very low dead-space volume extension sets when possible - this provides the most rapid achievement of steady-state drug delivery 6. The standard extension set systems can take up to 40 minutes to reach steady state after onset or flow changes 6.

If using a double-pump method with constant saline carrier flow:

• Maintain saline flow at 5 mL/h for most reliable delivery 6
• This minimizes delays in drug delivery during dose changes

Vascular Access

• Insert a plastic IV catheter through a suitable bore needle well advanced centrally into a large vein 1
• Secure with adhesive tape; avoid catheter tie-in techniques that promote stasis 1
• Use an IV drip chamber or metering device to permit accurate flow rate estimation 1

Peripheral Administration (When Central Access Delayed)

Peripheral administration is acceptable as a temporizing measure:

• Maximum duration: 24 hours 7
• Maximum dose: 0.2 mcg/kg/min through peripheral access 5
• Use 18-20 gauge catheter in appropriate site 7
• Inspect site every 2 hours for signs of infiltration 7
• In pediatric patients, peripheral or intraosseous routes were used safely for median 3 hours without adverse effects 5

Monitoring Requirements

Essential Monitoring

• Continuous blood pressure monitoring - every minute if possible during titration 3
• Continuous ECG monitoring to detect arrhythmias 3
• Central venous pressure (CVP) monitoring is helpful for detecting occult volume depletion 1
• Pulse oximetry for oxygen saturation 3

Hemodynamic Goals

• Mean arterial pressure (MAP) - CVP should be normalized 4
• Central venous oxygen saturation (ScvO2) >70% 4
• Cardiac index 3.3-6.0 L/min/m² in pediatric patients 4

Site Monitoring for Extravasation

• Visual inspection every 2 hours when using peripheral access 7
• Check for blood return on initiation and ongoing 7
• If extravasation occurs: inject phentolamine 0.1-0.2 mg/kg (up to 10 mg) diluted in 10 mL normal saline intradermally at the site 8

Critical Pitfalls and Precautions

Volume Resuscitation First

Always correct blood volume depletion before starting norepinephrine - give 20 mL/kg boluses of isotonic saline or colloid up to 60 mL/kg in children 4, or 1-2 L in adults at 5-10 mL/kg in first 5 minutes 3. Vasopressors should not substitute for adequate fluid resuscitation.

Arrhythmia Risk

Risk of potentially lethal arrhythmias exists, particularly with IV bolus administration 3. Continuous infusion via pump is safer than bolus dosing. Norepinephrine caused arrhythmias in only 2 of 144 pediatric patients in one series, neither requiring treatment 5.

Tissue Ischemia

Extravasation can cause severe skin injury and tissue necrosis 8. This risk necessitates careful site monitoring and preferential use of central access for prolonged infusions or high doses.

Obesity Considerations

Obese patients require lower weight-based doses (mean 0.09 mcg/kg/min) compared to non-obese patients (0.13 mcg/kg/min), but similar total doses (8-9 mcg/min) 9. Consider using actual body weight for initial dosing calculations in obese patients.

Concurrent Medications

• β-blocker therapy complicates treatment - consider glucagon 1-5 mg IV over 5 minutes followed by infusion if norepinephrine response is inadequate 3
• Patients may require additional vasopressors (dopamine, vasopressin) if refractory to norepinephrine alone 3

Timing Considerations

In septic shock, begin norepinephrine within 15 minutes if fluid-refractory (after initial 60 mL/kg fluid resuscitation in children) 4. Early vasopressor support is critical to prevent prolonged hypotension and end-organ damage.